vs

Side-by-side financial comparison of IRIDEX CORP (IRIX) and MicroAlgo Inc. (MLGO). Click either name above to swap in a different company.

MicroAlgo Inc. is the larger business by last-quarter revenue ($26.3M vs $14.7M, roughly 1.8× IRIDEX CORP). On growth, MicroAlgo Inc. posted the faster year-over-year revenue change (-35.5% vs -69.7%).

IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.

MicroAlgo Inc. is a technology enterprise specializing in custom algorithm optimization solutions. It mainly serves clients across smart city management, industrial internet, and e-commerce sectors, helping enterprises improve operational efficiency, reduce operating costs, and optimize data processing performance for real business scenarios.

IRIX vs MLGO — Head-to-Head

Bigger by revenue
MLGO
MLGO
1.8× larger
MLGO
$26.3M
$14.7M
IRIX
Growing faster (revenue YoY)
MLGO
MLGO
+34.2% gap
MLGO
-35.5%
-69.7%
IRIX

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
IRIX
IRIX
MLGO
MLGO
Revenue
$14.7M
$26.3M
Net Profit
Gross Margin
37.2%
Operating Margin
Net Margin
Revenue YoY
-69.7%
-35.5%
Net Profit YoY
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRIX
IRIX
MLGO
MLGO
Q4 25
$14.7M
Q3 25
$12.5M
Q2 25
$13.6M
$26.3M
Q1 25
$11.9M
Q4 24
$12.7M
$34.6M
Q3 24
$11.6M
Q2 24
$12.6M
$40.8M
Q1 24
$11.8M
Net Profit
IRIX
IRIX
MLGO
MLGO
Q4 25
Q3 25
$-1.6M
Q2 25
$-994.0K
Q1 25
$-1.7M
Q4 24
$-834.0K
$4.2M
Q3 24
$-1.9M
Q2 24
$-2.7M
Q1 24
$-3.5M
Gross Margin
IRIX
IRIX
MLGO
MLGO
Q4 25
37.2%
Q3 25
32.1%
Q2 25
34.5%
Q1 25
42.5%
Q4 24
44.0%
26.4%
Q3 24
37.3%
Q2 24
40.7%
Q1 24
37.9%
Operating Margin
IRIX
IRIX
MLGO
MLGO
Q4 25
Q3 25
-11.3%
Q2 25
-6.9%
Q1 25
-1.7%
Q4 24
-3.9%
7.0%
Q3 24
-16.1%
Q2 24
-20.9%
Q1 24
-28.0%
Net Margin
IRIX
IRIX
MLGO
MLGO
Q4 25
Q3 25
-12.6%
Q2 25
-7.3%
Q1 25
-14.2%
Q4 24
-6.6%
12.1%
Q3 24
-16.7%
Q2 24
-21.2%
Q1 24
-29.5%
EPS (diluted)
IRIX
IRIX
MLGO
MLGO
Q4 25
Q3 25
$-0.09
Q2 25
$-0.06
Q1 25
$-0.10
Q4 24
$-0.05
$0.56
Q3 24
$-0.12
Q2 24
$-0.16
Q1 24
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRIX
IRIX
MLGO
MLGO
Cash + ST InvestmentsLiquidity on hand
$6.0M
$319.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$317.6M
Total Assets
$29.2M
$330.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRIX
IRIX
MLGO
MLGO
Q4 25
$6.0M
Q3 25
$5.6M
Q2 25
$6.8M
$319.4M
Q1 25
$7.2M
Q4 24
$2.4M
$164.9M
Q3 24
$3.9M
Q2 24
$4.1M
$66.7M
Q1 24
$5.4M
Total Debt
IRIX
IRIX
MLGO
MLGO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$1.0M
Q3 24
$1.4M
Q2 24
Q1 24
Stockholders' Equity
IRIX
IRIX
MLGO
MLGO
Q4 25
Q3 25
$4.7M
Q2 25
$6.1M
$317.6M
Q1 25
$852.0K
Q4 24
$2.1M
$144.9M
Q3 24
$2.6M
Q2 24
$4.2M
$76.0M
Q1 24
$6.5M
Total Assets
IRIX
IRIX
MLGO
MLGO
Q4 25
$29.2M
Q3 25
$28.4M
Q2 25
$31.6M
$330.8M
Q1 25
$34.2M
Q4 24
$29.1M
$176.3M
Q3 24
$30.2M
Q2 24
$31.2M
$107.6M
Q1 24
$34.1M
Debt / Equity
IRIX
IRIX
MLGO
MLGO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.48×
Q3 24
0.53×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons